Supplement: Molecular Mysteries

1,2 "They have positive symptoms, they have negative symptoms, they have cognitive deficits that look very much like what you see in schizophrenia," says NYU's Javitt. For example, NMDA receptors are involved in the formation of memories but not in the retention of old memories; similarly, patients with schizophrenia have trouble forming, but not retaining, memories, Javitt says. NMDA receptors are also involved in pitch matching in the auditory cortex and in certain visual tasks, and schiz

Written byMelinda Wenner
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

For example, NMDA receptors are involved in the formation of memories but not in the retention of old memories; similarly, patients with schizophrenia have trouble forming, but not retaining, memories, Javitt says. NMDA receptors are also involved in pitch matching in the auditory cortex and in certain visual tasks, and schizophrenia patients have trouble detecting changes in pitch and in performing certain visual tasks.

Article continued below

To confirm that these symptoms are caused by the drug itself rather than by factors associated with drug abuse, John Krystal, a clinical pharmacologist and psychiatrist at Yale University, administered low doses of ketamine to healthy subjects in 1992 and achieved similar results.3 Krystal points out, however, that administering ketamine is not the same thing as having schizophrenia. "It mainly produces this one effect of blocking NMDA glutamate receptors, and schizophrenia is very likely to affect, in primary ways, multiple systems of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies